The fair value of Marico (MARICO), built from its filed accounts — ten years of results, the method that fits this business, and what today's price already assumes.
The market expects Marico to do better than it ever has.
At today’s share price, buyers are assuming Marico grows about 13% a year, forever. Over the last ten years it actually grew about 9% a year. So the share price only makes sense if the business improves on its own track record. If it simply carries on as before, buyers today have paid for something they will not get.
Worked backwards from today's share price: the growth today’s price implies for Marico, against what the model assumes.
How to read this. The number on the left is the growth today’s share price quietly takes for granted. The number on the right is what the model actually assumes. When the two are far apart, that gap is the bet you would be taking.
Revenue and earnings per share in ₹, return on equity and leverage as ratios — all from the filed statements.
Revenue and net profit as filed, in ₹ crore.
| Year | Revenue | Net profit | Margin |
|---|---|---|---|
| FY2018 | 6,333 | 827 | 13.1% |
| FY2019 | 7,334 | 1,135 | 15.5% |
| FY2020 | 7,315 | 1,043 | 14.3% |
| FY2021 | 8,048 | 1,199 | 14.9% |
| FY2022 | 9,512 | 1,255 | 13.2% |
| FY2023 | 9,764 | 1,322 | 13.5% |
| FY2024 | 9,653 | 1,502 | 15.6% |
| FY2025 | 10,831 | 1,658 | 15.3% |
| FY2026 | 13,611 | 1,813 | 13.3% |
This business is valued on the cash it is expected to generate, discounted back at its cost of capital — with growth taken from its own ten-year record rather than from guidance.
Discounted cash flowUnderstand this method
The same valuation, run side by side.
Marico vs Hindustan UnileverA focused edible-oils and hair-care book against the FMCG benchmark.→Marico vs Dabur IndiaThe closest peer on category mix and rural exposure.→Marico vs Godrej ConsumerTwo mid-cap consumer names side by side.→At ₹791 the market is pricing in roughly 13% sustained growth, against the ~9% its own record supports. That is more than it has delivered, so the price is justified only if the business can hold a rate it has not previously sustained.
It is computed from the filed financial statements using the method that fits this business (discounted cash flow), with every assumption shown alongside the result. The per-share figure and the full working are in the report.
Revenue went from ₹0.06 lakh crore to ₹0.14 lakh crore over the period shown, while return on equity moved from 43.0% to 81.9%. Growing scale on a rising return is a very different proposition from growing scale on a falling one.
From published financial statements. The method is chosen to fit the business — a bank on excess return, a regulated utility on its rate base, a conglomerate by its parts — and every assumption is shown with its source. When the numbers do not support an estimate, no estimate is published. This is an educational research tool: it reports what the model computed and does not recommend buying or selling anything.
A cost of capital of 9.43%, growth drawn from the company's own record rather than from guidance, and the valuation method that fits the business. All of them are listed in the report, with how much each one moves the answer.